Melanotan II is a synthetic melanocortin receptor agonist studied in research settings only. Patients can request a telehealth evaluation through the TelosRX Telehealth Portal to discuss whether compounded access is clinically appropriate.
What Is Melanotan II?
Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone. It is a research compound that binds to multiple melanocortin receptors.
Melanotan II is not an FDA-approved drug. It is available only through compounding pharmacies under valid prescription when clinically appropriate.
Important Safety Notes
Melanotan II carries notable safety considerations and is not appropriate for many patients. A licensed provider evaluates each case individually.
Provider discussion points may include:
- Medical history review
- Risk-benefit assessment
- Monitoring requirements
- Alternative options
Pre-PCAC July 2026 Regulatory Context
Melanotan II is among the compounds under PCAC review ahead of the July 2026 meeting. Compounded access may change following regulatory decisions.
How TelosRX Handles Melanotan II
TelosRX is an online-first telehealth service. Patient evaluation is asynchronous, and Melanotan II preparations are patient-specific and prescription-only.
- Step 1: Complete an asynchronous telehealth intake at TelosRX.
- Step 2: Licensed provider review with thorough risk evaluation.
- Step 3: Prescription issued only if clinically appropriate.
- Step 4: Compounded formulation ships discreetly to your door if approved.
Important Compliance Information
Melanotan II is not FDA-approved. Compounded preparations are prepared under federal compounding regulations.
Prescriptions require thorough evaluation by a licensed healthcare provider. Approval is not guaranteed. Individual results vary.
TelosRX operates under LegitScript-certified telehealth standards and exercises particular care with compounds that carry elevated safety considerations.
Start your private evaluation at TelosRX.